Area of research
Hepatology · Oncology
Research interest
Research interests include Medicine, Internal medicine, Oncology, Refractory (planetary science), Ipilimumab, and Clinical endpoint.
Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti–PD-1 Refractory Melanoma
Intratumoral Injection of <i>Clostridium novyi</i> -NT Spores in Patients with Treatment-refractory Advanced Solid Tumors
SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer
A phase 2 study to evaluate the safety and efficacy of Intratumoral (IT) injection of the TLR9 agonist IMO-2125 (IMO) in combination with ipilimumab (ipi) in PD-1 inhibitor refractory melanoma.
Abstract GS3-08: Pathological complete response predicts event-free and distant disease-free survival in the I-SPY2 TRIAL
The Effect of Needle Gauge on the Risk of Pneumothorax and Chest Tube Placement After Percutaneous Computed Tomographic (CT)-Guided Lung Biopsy
Intratumoral injection of <i>Clostridium novyi</i> -NT spores induces antitumor responses